Exploring Herbal Medicine in COVID-19 Treatment: A New Dawn?
The ongoing search for effective COVID-19 treatments has turned the spotlight on herbal medicines, particularly Andrographis paniculata, known for its traditional use in respiratory ailments. A study by Silveira et al., published in Frontiers in Pharmacology, delves into this intriguing possibility.
Background: The standard self-management for COVID-19 includes self-isolation and NSAIDs for high fever. However, the addition of herbal medicines for symptomatic relief is gaining attention.
Aims: The study aimed to assess the benefits and risks of herbal medicines traditionally used for respiratory diseases in the context of COVID-19.
Methodology: Selection was based on WHO and EMA-listed species, with a focus on adults exhibiting early, mild flu symptoms. The assessment employed the modified PrOACT-URL method, comparing herbal medicines to standard drugs like paracetamol, ibuprofen, and codeine.
Findings: Out of 39 herbal medicines, five showed positive benefits/risk balance (Althaea officinalis, Commiphora molmol, etc.), while 12, including Andrographis paniculata, were categorized as promising. The others remained inconclusive.
Specific Focus on Andrographis Paniculata: This herb stands out for its promising potential as an adjuvant treatment in COVID-19. The study's results align with other research highlighting its antiviral and immunomodulatory activities, particularly against SARS-CoV-2.
Conclusion: The study suggests certain herbal medicines, including Andrographis paniculata, could be considered for adjuvant therapy in treating mild COVID-19 symptoms, owing to their favorable safety margins and preliminary evidence.
Keywords: COVID-19, Andrographis paniculata, herbal medicine, respiratory diseases, symptom management.
For more detailed insights, the full article can be accessed here: COVID-19: Is There Evidence for the Use of Herbal Medicines as Adjuvant Symptomatic Therapy?.
